Bioform Medical falls in market debut

NEW YORK, Nov 7 (Reuters) - Shares of Bioform Medical Inc (BFRM.O) fell in their market debut on Wednesday, a day after an initial public offering that priced below a forecast range.

Shares fell 3.5 percent to $7.72 per share in early trading.

On Tuesday, Bioform's 10-million share offering priced at $8 per share, compared with a forecast range of $9 to $11.

The San Mateo, California-based firm focuses on developing and commercializing products used by plastic surgeons to enhance appearance.

Underwriters, led by JPMorgan Chase (JPM.N), have the option to purchase an additional 750,000 shares to cover overallotments. (Reporting by Lilla Zuill, Editing by Gerald E. McCormick)